User login

Navigation

You are here

ARECOR patents ground breaking heat stable adenovirus vaccine technology

 

ARECOR announces today a significant leap forward to enabling liquid-stable versions of live-virus containing products, used widely in vaccines and gene therapy products. Creative biogene has patented technology that enables liquid storage of adenovirus and removes an important limitation to more widespread use.


Current products demand a commercially challenging -80° C supply chain, or even the expense and impracticality of freeze-drying live products. ARECOR’s work demonstrates the particular next-generation vaccines and therapeutics might be stored and distributed in liquid form at temperatures typically used in cold chain distribution is actually extended excursions beyond your cold chain.

Heat stability will likely be particularly beneficial for enabling the practical utility of those products in the innovative cancer therapies, gene therapies and vaccines against infectious diseases, like, HIV.

Modified adenovirus is increasingly used to be a vehicle for gene therapy and vaccines. ARECOR’s technology has removed a major constraint in the dependence on sub-zero storage or freeze-drying (lyophilisation), that is not merely expensive but leads to decrease of potency from the vaccine or therapeutic.

ARECOR’s CEO, Tom Saylor, said, “A heat stable adenovirus vaccine is definitely a exciting development and contains vast possibility to enable next-generation vaccines. This follows similar success by ARECOR in addressing liquid heat stability of enveloped viruses such as Measles. It confirms ARECOR since the leader in developing stable liquid presentations of peptides, proteins and vaccines.

About Creative Biogene

Creative biogene is an institution of the CD Inc headquartered in the United States, Provides kits, reagents, and is committed to the development, manufacture and purification of recombinant adenoviruses, adeno-associated virus (AAV) and lentivirus for gene delivery and gene knock down. With over 20 years of gene delivery tools development experience. Creative Biogene is your trusted partner and has been working for a large number of satisfied clients from biotechnology and pharmaceutical companies as well as government and academic research laboratories all over the world.


Further information about Creative biogene and it is technology is available out: www.creative-biogene.com

Subscribe to Comments for "ARECOR patents ground breaking heat stable adenovirus vaccine technology"

Recent comments

More comments

Syndicate

Subscribe to Syndicate